Table 2 Descriptive analysis: outcomes in 1-year follow-up period
Outcome | Total N = 21,524 |
|---|---|
Maintenance treatment rate, n (%) | 5,445 (25.3%) |
COPD exacerbation rate (overall), n (%) | 2,751 (12.8%) |
Requiring hospitalization/ED visit | 417 (1.9%) |
Number of COPD exacerbations (overall), mean (SD) | 0.18 (0.57) |
Requiring hospitalization/ED visit | 0.02 (0.15) |
Total COPD-related cost per patient, mean (SD) (pharmacy + medical) | $594 (1,626) |
COPD-related pharmacy costs | $293 (542) |
COPD-related medical costs | $301 (1,431) |